e-learning
resources
Virtual 2021
05.09.2021
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
J. Paluero (Värnamo, Sweden), L. Tokhi (Värnamo, Sweden), M. Roglic (Värnamo, Sweden), M. Labor (Värnamo, Sweden)
Source:
Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session:
COVID-19 and obstructive diseases: risk factors, management and long-term effects
Session type:
E-poster
Number:
961
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Paluero (Värnamo, Sweden), L. Tokhi (Värnamo, Sweden), M. Roglic (Värnamo, Sweden), M. Labor (Värnamo, Sweden). Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor. 961
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study
Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020
Year: 2020
The role of infections in acute exacerbations of COPD
Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know?
Year: 2005
COPD as an additional risk factor for cardiovascular and respiratory events in patients with respiratory viral infection
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
One-year follow up of patients hospitalized for acute exacerbation of COPD related to viral infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Is RSV positive testing predictive of a more severe course of disease in patients with acute bronchiolitis admitted to hospital?
Source: Eur Respir J 2005; 26: Suppl. 49, 627s
Year: 2005
Respiratory syncitial virus infection in hospitalized Brazilian infants with acute lower respiratory disease: incidence and associated factors
Source: Eur Respir J 2005; 26: Suppl. 49, 628s
Year: 2005
The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 277s
Year: 2002
Response to non-invasive ventilation as a predictor for mortality in patients with acute respiratory failure due to acute exacerbation of COPD
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017
Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS)
Source: Eur Respir J 2004; 24: Suppl. 48, 239s
Year: 2004
Acute exacerbation of COPD (AECOPD) during pulmonary rehabilitation (PR): impact on outcomes and short-term prediction of risk.
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Can seriousness of respiratory failure be predicted by the values of clinical score in patients with acute severe asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001
The role of viral infections in patients admitted with acute exacerbation of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 408s
Year: 2004
Clinical characteristics and risk factors of virus or influenza infection among the hospitalized pneumonia in COPD patients
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018
Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020
Year: 2021
Correspondence between clinical prediction and outcome in patients with acute hypercapnic respiratory failure (AHRF) due to restrictive lung disease
Source: Annual Congress 2012 - Application of noninvasive ventilation in non-obstructive patients
Year: 2012
The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded)
Source: Eur Respir Mon; 2008: 41: 60–71
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept